Biodexa Pharmaceuticals Plc (BDRX) AI Dilution Summary
Updated Oct 8, 2026
Cash was $3,230,000 at 2026-06-30 against estimated monthly burn of $768,500. The most recent capital raised was the financing closed 2026-09-15, which raised $2,300,000 gross from 2,204,218 shares at $1.05 per share through placement agent Maxim Group LLC; an earlier registered direct offering closed 2026-07-01 raised $3,540,000 gross. Dilution here is driven primarily by the equity line, with $26,080,000 of remaining capacity.